Dr. Scott R. Karlan, MD

Dr. Karlan practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Karlan's NPI, 1982688982, was assigned on December 2, 2005. Dr. Karlan graduated from Harvard Medical School in 1982. Dr. Karlan's California license number on file is G57520.

Dr. Karlan's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Karlan's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Cedars-Sinai Medical Center. Dmand AI also links Dr. Karlan to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Karlan practices. Vendor and product names are available with a free account.

Surgical oncology is Dr. Karlan's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Karlan is board certified in surgery by the American Board of Surgery. Dr. Karlan has a license on file in California.

Dmand AI lists mastectomy among the conditions Dr. Karlan treats.

CMS data shows 576 Medicare services from Dr. Karlan across 12 procedure codes in 2024, for 296 Medicare patients. Medicare paid $55,480 for them.

CMS counts 296 Medicare patients who saw Dr. Karlan in 2024. The largest group is 65 to 74, with 141 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 19% are also on Medicaid. Their average risk score is 1.04, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Karlan's median patient age at 72, with 99% women.

In 2024, Dr. Karlan wrote 79 Medicare Part D claims for 38 patients. 100% of them were for generic drugs. CMS names the drug for 69 of them, across 2 drugs with 11 or more claims each, at $1,931 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Karlan for performance year 2024, reported as part of a group. Dr. Karlan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 32 procedures of mastectomy by Dr. Karlan, more than 88% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Karlan in 2024. 2024 was the busiest year, with 2. The most frequent topics are Breast Neoplasms. Dr. Karlan's most frequent co-authors are Reva Kakkar Basho, MD, Alice P. Chung, MD and Gaorav Pankaj Gupta, MD, PhD.

Dmand AI links Dr. Karlan to 4 clinical trials. 2 are still active or recruiting. Conditions studied include Carcinoma, Intraductal, Noninfiltrating, Breast Carcinoma In Situ and Pain, Postoperative.

Dmand AI lists 7 awards for Dr. Karlan, most recently America's Top Doctors in 2014.

Dr. Karlan graduated from Harvard Medical School in 1982. Dr. Karlan is a member of ACS.

Dr. Karlan is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.